Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens (Q34895083)

5 August 2017

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens (English)

1 reference

5 August 2017

0 references

1 reference

6

Patricia Hartge

1 reference

5 August 2017

Eleftherios P. Diamandis

object named as

Eleftherios P Diamandis

4

0 references

Robert C. Bast

object named as

Robert C Bast

2

0 references

Paul F Pinsky

12

object named as

Paul F Pinsky

1 reference

5 August 2017

3

Christine D Berg

1 reference

5 August 2017

8

Karen H Lu

1 reference

5 August 2017

1

Daniel W Cramer

1 reference

5 August 2017

Andrew K Godwin

5

1 reference

5 August 2017

Anna E Lokshin

7

1 reference

5 August 2017

Martin W McIntosh

9

1 reference

5 August 2017

Gil Mor

10

1 reference

5 August 2017

Christos Patriotis

11

1 reference

5 August 2017

Mark D Thornquist

13

1 reference

5 August 2017

Nathalie Scholler

14

1 reference

5 August 2017

Steven J Skates

15

1 reference

5 August 2017

Patrick M Sluss

16

1 reference

5 August 2017

Sudhir Srivastava

17

1 reference

5 August 2017

David C Ward

18

1 reference

5 August 2017

Zhen Zhang

19

1 reference

5 August 2017

Claire S Zhu

20

1 reference

5 August 2017

Nicole Urban

21

1 reference

5 August 2017

language of work or name

1 reference

1 March 2011

1 reference

Cancer Prevention Research

5 August 2017

1 reference

5 August 2017

4

1 reference

5 August 2017

3

1 reference

5 August 2017

365-374

1 reference

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Clinical practice. Screening for ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Results from four rounds of ovarian cancer screening in a randomized trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

A serum based analysis of ovarian epithelial tumorigenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Serum protein markers for early detection of ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Blood and urine markers for ovarian cancer: a comprehensive review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Use of proteomic patterns in serum to identify ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Phases of biomarker development for early detection of cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Screening for ovarian cancer: a pilot randomised controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Ovarian cancer: to screen or not to screen.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Standardizing diagnostic markers to evaluate and compare their performance

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085251

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21372036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21372036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diagnostic markers for early detection of ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21372036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1940-6207.CAPR-10-0195

1 reference

5 August 2017

1 reference

5 August 2017

1 reference